Literature DB >> 3035718

The role of individual cysteine residues in the structure and function of the v-sis gene product.

N A Giese, K C Robbins, S A Aaronson.   

Abstract

The v-sis oncogene encodes a platelet-derived growth factor (PDGF)-related product whose transforming activity is mediated by its functional interaction with the PDGF receptor. PDGF, as well as processed forms of the v-sis gene product, is a disulfide-linked dimer with eight conserved cysteine residues in the minimum region necessary for biologic activity. Site-directed mutagenesis of the v-sis gene revealed that each conserved cysteine residue was required directly or indirectly for disulfide-linked dimer formation. However, substitution of serine for cysteine codons at any of four positions had no detrimental effect on transforming activity of the encoded v-sis protein. These results establish that interchain disulfide bonds are not essential in order for this protein to act as a functional ligand for the PDGF receptor. The remaining four substitutions of serine for cysteine each inactivated transforming function of the molecule. In each case this was associated with loss of a conformation shown to involve intramolecular disulfide bonds. These studies provide insight into the role of individual cysteine residues in determining the structure of the sis/PDGF molecule critical for biological activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035718     DOI: 10.1126/science.3035718

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  16 in total

1.  Recent developments in the structure, function and regulation of platelet-derived growth factor and its receptors.

Authors:  J Tiesman; A Rizzino
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  Expression and purification of biologically active v-sis/platelet-derived growth factor B protein by using a baculovirus vector system.

Authors:  N Giese; M May-Siroff; W J LaRochelle; K van Wyke Coelingh; S A Aaronson
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  Immunochemical localization of the epitope for a monoclonal antibody that neutralizes human platelet-derived growth factor mitogenic activity.

Authors:  W J LaRochelle; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

4.  Identification of nonessential disulfide bonds and altered conformations in the v-sis protein, a homolog of the B chain of platelet-derived growth factor.

Authors:  M K Sauer; D J Donoghue
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

5.  A small v-sis/platelet-derived growth factor (PDGF) B-protein domain in which subtle conformational changes abrogate PDGF receptor interaction and transforming activity.

Authors:  N Giese; W J LaRochelle; M May-Siroff; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

6.  Expression of platelet-derived growth factor (PDGF)-related transcripts and synthesis of biologically active PDGF-like proteins by human malignant epithelial cell lines.

Authors:  E Sariban; N M Sitaras; H N Antoniades; D W Kufe; P Pantazis
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

7.  Dual roles of an essential cysteine residue in activity of a redox-regulated bacterial transcriptional activator.

Authors:  Nirupama Gupta; Stephen W Ragsdale
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

8.  Primary structure of the human fgr proto-oncogene product p55c-fgr.

Authors:  S Katamine; V Notario; C D Rao; T Miki; M S Cheah; S R Tronick; K C Robbins
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

9.  Partially transformed, anchorage-independent human diploid fibroblasts result from overexpression of the c-sis oncogene: mitogenic activity of an apparent monomeric platelet-derived growth factor 2 species.

Authors:  C W Stevens; W H Brondyk; J A Burgess; T H Manoharan; B G Häne; W E Fahl
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

10.  The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D.

Authors:  W C Wilcox; D Long; D L Sodora; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.